Mycronic receives order for an FPS mask writer from a customer in the US

Report this content

Täby, 4 August, 2015 - Mycronic AB (publ), has received order for an FPS mask writer within the multi-purpose segment from a customer in the US. The system is scheduled for delivery during the third quarter of 2016.

Mycronic offers mask writers for manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market. The multi-purpose market is a broad segment comprising many different application areas, including touch screen photomasks and electronic packaging.

“Mycronic´s FPS is well positioned for applications within this segment for less critical photomasks. The choice of the FPS shows the customer’s continued confidence in Mycronic. The flexibility and reliability of the system provides the customer with a cost effective photomask manufacturing for a wide variety of application areas”, says Magnus Råberg, Senior VP and General Manager Pattern Generators of Mycronic AB. “It is gratifying that we are so well positioned in this competitive market.”

The competitive multi-purpose market is a good complement to Mycronic´s mask writers for advanced displays. The price level for an FPS is between USD 1.5–4 million, depending on configuration and customization.

Contacts at Mycronic:
Magnus Råberg
Sr VP & General Manager PG
Tel: +46 8 638 52 00
magnus.raberg@mycronic.com

Per Ekstedt
CFO
Tel: +46 8 638 52 00
per.ekstedt@mycronic.com
 
 

About Mycronic AB
Mycronic AB is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany Japan, Singapore, South Korea, the Netherlands, United Kingdom and the United States. For more information see our web site at:
www.mycronic.com 

Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.

The information is of the type that Mycronic is required to disclose under the Financial Instruments trading Act and/or the Swedish Securities Markets Act and was submitted for publication at 18.00 on 4 August, 2015.

Subscribe

Documents & Links